Pharma packaging company Schott Pharma has unveiled plans to establish a new manufacturing facility in Wilson, North Carolina. Schott Pharma says the $371 million investment in the U.S. facility will create more than 400 jobs in the region and significantly expand the company’s presence in the U.S., an increasingly important strategic market for the German…
Telix Pharmaceuticals to buy ARTMS and its isotope production platform
Telix Pharmaceuticals announced that it agreed to acquire radioisotope production technology firm ARTMS Inc. ARTMS also brings with it an advanced cyclotron-based isotope production platform and manufacturing plant. It has a stockpile of ultra-pure rare metals required for consumable target production, too, according to a news release. The company specializes in the physics, chemistry and…
Catalent cuts 300 jobs ahead of acquisition by Novo Holdings
Catalent said this week that it reduced its headcount by approximately 300 employees as part of a restructuring effort. The company confirmed the workforce reduction in its 10-Q quarterly report, filed on Feb. 14. This also coincides with preparations for an acquisition as Novo Holdings agreed to buy the leading pharmaceutical CDMO for $16.5 billion…
Bora Pharmaceuticals is buying generics maker Upsher-Smith
Bora Pharmaceuticals announced that its board approved the acquisition of Upsher-Smith Laboratories for up to $210 million. Minnesota-based Upsher-Smith features a diversified portfolio of 48 generic products. It has manufacturing facilities in Plymouth and Maple Grove, Minnesota. Taipei, Taiwan-based Bora called the company a reliable partner with solid manufacturing capabilities, a robust distribution network and…
Two continents, two milestones: Schott Pharma’s American commitment and European stock market debut
Drug containment company Schott Pharma recently celebrated major milestones related to its longstanding U.S. presence and high-profile stock market debut in Germany. The company, a division of specialty glass manufacturer Schott AG based in Mainz, Germany, commemorated 60 years of operations in the U.S. in August. Its primary American facility located in Lebanon County, Pennsylvania…
HHS awards more than $1 billion to advance next-gen COVID-19 vaccines and therapeutics
The U.S. Department of Health and Human Services (HHS) has awarded $1.4 billion to support vaccine clinical trials to test new, more effective and longer-lasting COVID-19 vaccines. In all, Project NextGen is a $5 billion initiative from Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The…
Decade-plus review of drug recall trends from 2011 to 2023
Earlier this year, we took a look at the most common causes of drug-related recalls in 2022 and the first quarter of 2023. Now, we are expanding our lens to examine drug-related FDA recalls from 2011 to 2023. Understanding the recall landscape In recent decades, prominent incidents like the Tylenol poisonings in 1982 have underscored…
3M to invest nearly $150M to boost biopharma filtration tech capabilities
3M (NYSE: MMM) today announced today that it will invest $146 million dollars to expand its capabilities to further support the fast-growing biotech manufacturing sector. The investment will include facility and equipment improvements and 60 new full-time positions in 3M manufacturing facilities in Europe. 3M said the new investment will accelerate its development and delivery of vital…
Baxter to divest its BioPharma Solutions business for $4.25B
Baxter continues to streamline, announcing today that it will sell its pharma and biotech contract manufacturing business. The Deerfield, Illinois-based medtech company — maker of diagnostic, critical care, kidney care, nutrition, hospital and surgical products and services — will sell its BioPharma Solutions (BPS) business to private equity firms Advent International and Warburg Pincus. Baxter…
SMC’s European division gets new VP and GM
Medical device and pharmaceutical contract manufacturer SMC announced today that it has appointed Uri Baruch as the new VP and GM of its European division, which includes Oval Medical Technologies and Cambridge Pharma. The appointment is effective immediately. Cambridge, U.K.–based SMC says Baruch has a wealth of experience and a proven track record of success…